KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Shares Repurchased (2016 - 2022)

Amgen has reported Shares Repurchased over the past 14 years, most recently at $6.4 billion for Q1 2022.

  • For Q1 2022, Shares Repurchased rose 630.2% year-over-year to $6.4 billion; the TTM value through Dec 2022 reached $6.4 billion, up 27.84%, while the annual FY2024 figure was $200.0 million, N/A changed from the prior year.
  • Shares Repurchased for Q1 2022 was $6.4 billion at Amgen, up from $1.4 billion in the prior quarter.
  • Over five years, Shares Repurchased peaked at $10.7 billion in Q1 2018 and troughed at $555.0 million in Q2 2020.
  • A 5-year average of $2.4 billion and a median of $1.4 billion in 2021 define the central range for Shares Repurchased.
  • Biggest five-year swings in Shares Repurchased: skyrocketed 1725.43% in 2018 and later crashed 77.02% in 2020.
  • Year by year, Shares Repurchased stood at $2.1 billion in 2018, then plummeted by 48.49% to $1.1 billion in 2019, then increased by 10.15% to $1.2 billion in 2020, then grew by 19.75% to $1.4 billion in 2021, then soared by 340.75% to $6.4 billion in 2022.
  • Business Quant data shows Shares Repurchased for AMGN at $6.4 billion in Q1 2022, $1.4 billion in Q4 2021, and $1.1 billion in Q3 2021.